ALENDRONATE Drug Patent Profile
✉ Email this page to a colleague
When do Alendronate patents expire, and when can generic versions of Alendronate launch?
Alendronate is a drug marketed by Hikma, Novitium Pharma, Apotex, Aurobindo Pharma, Chartwell Rx, Cipla, Hangzhou Binjiang, Impax Labs Inc, Ipca Labs Ltd, Jubilant Cadista, Mylan, Rising, Sun Pharm, Teva Pharms, and Watson Labs. and is included in sixteen NDAs.
The generic ingredient in ALENDRONATE is alendronate sodium. There are twenty-five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alendronate
A generic version of ALENDRONATE was approved as alendronate sodium by AUROBINDO PHARMA on August 4th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ALENDRONATE?
- What are the global sales for ALENDRONATE?
- What is Average Wholesale Price for ALENDRONATE?
Summary for ALENDRONATE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 16 |
| Drug Prices: | Drug price information for ALENDRONATE |
| Drug Sales Revenues: | Drug sales revenues for ALENDRONATE |
| DailyMed Link: | ALENDRONATE at DailyMed |
US Patents and Regulatory Information for ALENDRONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 078638-001 | Aug 4, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Impax Labs Inc | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 075710-005 | Feb 6, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 090022-003 | Sep 10, 2008 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rising | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 076584-003 | Aug 4, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 090022-004 | Sep 10, 2008 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Watson Labs | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 076984-003 | Aug 4, 2008 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
